News + Filings Transactions Holdings
|
GADICKE ANSBERT
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/22/2023 | TCR2 THERAPEUTICS INC. | TCRR | Sale | Common Stock | 70.2k | $1.88 | $131.9k | See Footnote | 05/22/2023 |
| 05/22/2023 | TCR2 THERAPEUTICS INC. | TCRR | Exercise (in-the-money or at-the-money) | Common Stock Warrant (Right To Buy) | 42.8k | $0.74 | $31.6k | See Footnote | 05/22/2023 |
| 05/22/2023 | TCR2 THERAPEUTICS INC. | TCRR | Exercise (in-the-money or at-the-money) | Common Stock Warrant (Right to Buy) | 135.5k | $0.74 | $100.3k | See Footnote | 05/22/2023 |
| 07/28/2022 | Allovir, Inc. | ALVR | Grant | Common Stock | 3.3M | $4.61 | $15M | By ElevateBio LLC | 07/28/2022 |
| 06/22/2022 | Cullinan Oncology, Inc. | | Grant | Stock Option (Right to Buy) | 16.5k | $12.73 | $209.7k | | 06/22/2022 |
| 05/17/2022 | Allovir, Inc. | ALVR | Grant | Stock Option (Right to Buy) | 27.5k | $4.60 | $126.5k | | 05/17/2022 |
| 01/05/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 30.3k | $42.03 | $1.3M | See Footnote | 01/04/2022 |
| 01/04/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 158.6k | $42.05 | $6.7M | See Footnote | 01/04/2022 |
| 01/04/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 32.4k | $43.20 | $1.4M | See Footnote | 01/04/2022 |
| 01/04/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 11.3k | $45.32 | $512.9k | See Footnote | 01/04/2022 |
| 01/04/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 12.8k | $46.47 | $596.2k | See Footnote | 01/04/2022 |
| 12/07/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 30.1k | $33.15 | $996.5k | See Footnote | 12/03/2021 |
| 12/07/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 2.5k | $34.11 | $85.2k | See Footnote | 12/03/2021 |
| 12/06/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 14.2k | $32.35 | $458.5k | See Footnote | 12/03/2021 |
| 12/06/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 2k | $33.57 | $65.8k | See Footnote | 12/03/2021 |
| 12/06/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 850 | $34.08 | $29k | See Footnote | 12/03/2021 |
| 12/06/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 100 | $35.04 | $3.5k | See Footnote | 12/03/2021 |
| 12/03/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 29.4k | $34.68 | $1M | See Footnote | 12/03/2021 |
| 12/03/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 4k | $35.44 | $143.4k | See Footnote | 12/03/2021 |
| 12/03/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 300 | $36.26 | $10.9k | See Footnote | 12/03/2021 |
| 12/02/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 49.8k | $33.74 | $1.7M | See Footnote | 11/30/2021 |
| 12/02/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 12.4k | $34.83 | $433.1k | See Footnote | 11/30/2021 |
| 12/01/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 10.1k | $33.82 | $342k | See Footnote | 11/30/2021 |
| 12/01/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 9.1k | $34.61 | $316k | See Footnote | 11/30/2021 |
| 12/01/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 1.5k | $35.34 | $53k | See Footnote | 11/30/2021 |
| 11/30/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 9.8k | $34.62 | $339.6k | See Footnote | 11/30/2021 |
| 11/30/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 47k | $35.19 | $1.7M | See Footnote | 11/30/2021 |
| 11/29/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 16.9k | $34.46 | $580.9k | See Footnote | 11/26/2021 |
| 11/29/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 500 | $35.37 | $17.7k | See Footnote | 11/26/2021 |
| 11/26/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 11k | $35.49 | $388.7k | See Footnote | 11/26/2021 |
| 11/26/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 10.3k | $36.03 | $369.6k | See Footnote | 11/26/2021 |
| 11/24/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 8.1k | $35.20 | $286.8k | See Footnote | 11/17/2021 |
| 11/24/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 30.7k | $36.05 | $1.1M | See Footnote | 11/17/2021 |
| 11/24/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 22k | $37.02 | $813.1k | See Footnote | 11/17/2021 |
| 11/23/2021 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 32.9k | $36.21 | $1.2M | See Footnote | 11/17/2021 |
|
|